[Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia].
Lists
Only you see this
Abstract
Dasatinib is an effective and safe therapy option and can be used as first-line therapy for newly diagnosed CML-CP patients.
BibTeX
@inproceedings{zhou2013preliminary,
author = {Li Zhou and Jianxiang Wang and Xiao‐Jun Huang and Jianda Hu and Zhixiang Shen},
title = {{[Preliminary comparison of efficacy and safety of dasatinib and imatinib in newly diagnosed chronic myeloid leukemia].}},
booktitle = {PubMed},
year = {2013},
}Loading related content...